All In Biotech

Drug Trial Radar · NCT00296335

Trial of Adjuvant Chemotherapy for Gastric Cancer

A Phase III Randomized Controlled Trial of Adjuvant Chemotherapy for Advanced Gastric Adenocarcinoma

Last checked: Nov 19, 2026Latest source record: Feb 27, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 855 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

855

Actual

Start

Feb 2002

Primary completion

Nov 2007

Study completion Dec 2009

Sponsor

Lead sponsor
Asan Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Ulsan University Hospital; Hallym University Medical Center
First posted
Feb 27, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 69 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase III randomized study designed to evaluate the efficacy of mitomycin, doxifluridine, and cisplatin compared to mitomycin and doxifluridine.

Conditions

  • Stomach Cancer

Interventions

  • Mitomycin, doxifluridine and cisplatinDrug

    Mitomycin-C 20mg/m2 intravenously (day 1), Doxifluridine 460-600mg/m2/day per oral (day 28- day 336), Cisplatin 60mg/m2 intravenously (day 28, day 56, day 84, day 112, day 140, and day 168)

  • Mitomycin and doxifluridineDrug

    Mitomycin-C 20mg/m2 intravenously (day 1), Doxifluridine 460-600mg/m2/day per oral (day 28-day 84)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relapse-free Survival RateTime frame: 3 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Asan Medical Center

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.